Skip to content
2000
Volume 14, Issue 5
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

The development of O-phosphotyrosine (pTyr) analogues is reviewed, along with their application in peptidomimetic ligands to proteins implicated in disease-states arising from dysfunctional intracellular signal transduction pathways. Salient features of chemical syntheses are critiqued, including those of established mimetics such as 4'-(phosphonomethyl)phenylalanine (Pmp), 4'- (phosphono)phenylalanine (Ppp) and 4'-(phosphonodifluoromethyl)phenylalanine (F2Pmp), their respective (α-methyl)phenylalanine analogues and “preorganised” side-chain cyclised pTyr mimetics. Syntheses of 4'-(phosphinomethyl)phenylalanines are also described, as are “bone-directing” residues such as 4'-(diphosphonomethyl)phenylalanine (dpmF), 3',4'-(diphosphono)phenylalanine and 4'- carboxymethyloxy-3'-(phosphono)phenylalanine (CPP), capable of eliciting additional interactions with pTyr-binding subsites of specified proteins. The utility of [(4'-phosphonomethyl)phenyl]propenoic acid in current developments is also discussed as a route to a range of α- and β-substituted pTyr mimetics, and to pTyr mimetics bearing the requisite β-vinyl functionality to facilitate macrocyclisation via olefin metathesis - of interest in the development of structures exhibiting global conformational constraint. Finally, developments in prodrug presentation of pTyr mimetics are also discussed.

Loading

Article metrics loading...

/content/journals/coc/10.2174/138527210790601189
2010-03-01
2025-05-18
Loading full text...

Full text loading...

/content/journals/coc/10.2174/138527210790601189
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test